Costs for Acute Myocardial Infarction in a Tertiary Care Centre and Nationwide in France
- 1 June 2000
- journal article
- Published by Springer Nature in PharmacoEconomics
- Vol. 17 (6) , 603-609
- https://doi.org/10.2165/00019053-200017060-00006
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- [The impact of the data collection method on the medico-economic classification of admissions for myocardial infarction at the public hospitals in Lyon].1998
- Recommendations for Reporting Cost-effectiveness AnalysesJAMA, 1996
- Recommendations for reporting cost-effectiveness analyses. Panel on Cost-Effectiveness in Health and MedicineJAMA, 1996
- Economic Assessment of Platelet Glycoprotein IIb/IIIa Inhibition for Prevention of Ischemic Complications of High-Risk Coronary AngioplastyCirculation, 1996
- Cost Effectiveness of Thrombolytic Therapy with Tissue Plasminogen Activator as Compared with Streptokinase for Acute Myocardial InfarctionNew England Journal of Medicine, 1995
- Data Quality in a DRG-Based Information SystemInternational Journal for Quality in Health Care, 1994
- Lessons From France—'Vive la Différence'Published by American Medical Association (AMA) ,1993
- Lessons from France--'vive la difference'. The French health care system and US health system reformJAMA, 1993
- Market and Regulatory Influences on the Availability of Coronary Angioplasty and Bypass Surgery in U.S. HospitalsNew England Journal of Medicine, 1987
- Prospective reimbursement and the diffusion of new technologies in hospitalsJournal of Health Economics, 1984